Affordable Access

Publisher Website

New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus

Authors
Journal
Life Sciences
0024-3205
Publisher
Elsevier
Publication Date
Volume
91
Identifiers
DOI: 10.1016/j.lfs.2012.03.029
Keywords
  • Endothelium
  • Vasoconstriction
  • Inflammation
  • Oxidative Stress
  • Receptors
  • Glucose
  • Insulin Resistance
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Endothelin-1 (ET-1) is a vasoconstrictor, proinflammatory and proliferative endothelial cell-derived peptide that is of significant importance in the regulation of vascular function. It is involved in the development of endothelial dysfunction including important interactions with nitric oxide. The expression and functional effects of ET-1 and its receptors are markedly altered during development of cardiovascular disease. Increased production of ET-1 and its receptors mediate many pathophysiological events contributing to the development of atherosclerosis and vascular complications in diabetes mellitus. The present review focuses on the pathophysiological role of ET-1 and the potential importance of ET receptors as a therapeutic target for treatment of these conditions.

There are no comments yet on this publication. Be the first to share your thoughts.